SCHEMBL4696686

SCHEMBL4696686

CCOC(=O)c1c(Cl)c2ccc(-c3ccccc3)cc2[nH]c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.61
ALOX5 P09917 4/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
KDM4E B2RXH2 2/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 2/20 0.49
MAPT P10636 2/20 0.49
KMT2A Q03164 2/20 0.49
GAA P10253 1/20 0.49
MAPK10 P53779 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PTGES O14684 3/20 0.48
MAP3K5 Q99683 1/20 0.47
CYP1A2 P05177 1/20 0.47
XBP1 P17861 1/20 0.47
CYP2C19 P33261 1/20 0.47
TNKS2 Q9H2K2 1/20 0.47
ALOX15 P16050 1/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4701132 0.87 KDM5A (0.59) CSF1RALOX5ALDH1A1HPGDKDM4E
SCHEMBL14830067 0.85 CSF1R (0.54) CSF1RALOX5ALDH1A1HPGDKDM4E
SCHEMBL13739817 0.84 CSF1R (0.52) CSF1RALDH1A1KDM4ELMNAMEN1
SCHEMBL1061379 0.84 KDM4E (0.64) CSF1RALOX5ALDH1A1KDM4ELMNA
SCHEMBL7820686 0.78 CSF1R (0.69) CSF1RALDH1A1HPGDKDM4ELMNA
SCHEMBL4699400 0.77 CSF1R (0.53) CSF1RALOX5ALDH1A1HPGDKDM4E
SCHEMBL13295306 0.77 CSF1R (0.58) CSF1RALOX5ALDH1A1HPGDKDM4E
SCHEMBL31423243 0.76 CSF1R (0.45) CSF1RALDH1A1KDM4EMEN1KMT2A
SCHEMBL4849491 0.76 CSF1R (1.00) CSF1RALOX5ALDH1A1HPGDKDM4E
SCHEMBL14829946 0.75 KDM5A (0.47) CSF1RALOX5ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996553-A2 TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES Avanir Pharmaceuticals (US) 2008-12-03 EP disclosed
WO-2007109251-A2 TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES AVANIR PHARMACEUTICALS (US) 2007-09-27 WO disclosed